A program to improve cancer care for the community
Official title: Morehouse Total Cancer Care Protocol: A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer
Run by Morehouse School of Medicine · NCT04804878 · Data updated 2026-11-12
This study is trying to improve cancer care for African American patients by collecting health information and biological samples to help develop better treatments tailored to their needs.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 5000 (estimated) |
| Sponsor | Morehouse School of Medicine Academic / other |
| Locations | 1 site (Atlanta, Georgia) |
| Status | Recruiting |
| Started | April 5, 2018 |
| Main results expected | April 2035 |
| Study ends | April 2037 |
| Registry record updated | March 18, 2021 |
| Trial ID | NCT04804878 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals aged 18 and older who have been diagnosed with cancer or are at risk of developing cancer.
✕Probably not a fit
Patients who are under 18 years old or do not have a cancer diagnosis or risk may not benefit from this program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The Morehouse Total Cancer Care program aims to enhance cancer treatment standards by creating a centralized biorepository of biological samples and associated data from thousands of African American cancer patients and those at risk. This observational study will collect blood, tissue, and other biological samples, along with survey and medical records data, to facilitate biomarker discovery and personalized medicine approaches. Participants will provide informed consent to allow researchers to study their health information and biological materials over their lifetime. The initiative focuses on translating research findings into community oncology practices.
Why it matters
Potential benefit: If successful, this program could lead to improved cancer care and personalized treatment options for patients.
How similar studies have gone: Other studies have shown success in establishing biorepositories for cancer research, indicating that this approach is promising.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. 18 years of age and older. 2. Diagnosed with cancer, or at risk for cancer. This includes anyone in the general population, but our primary focus will be on patients with a cancer diagnosis. 3. Able to understand and sign the TCCP Informed Consent and Research Authorization form directly or through an authorized representative. The Informed Consent and Research Authorization will be available in both English and Spanish languages Exclusion Criteria: None \-
Where it's running
-
Morehouse School of Medicine
Atlanta, Georgia, United States Recruiting
Study contacts
- Principal investigator: James W Lillard, PhD — Morehouse School of Medicine
- Study coordinator: LaTrisha Horne
- Email: totalcancercare@msm.edu
- Phone: 404-752-1034
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Oncology biobank and longitudinal sample collection at NYCBS
This collects and stores blood, tissue, and health information from adults with cancer, people at higher risk, and healthy donors to help researchers test new cancer tests and treatments.
-
AI (Mirai)-guided supplemental MRI to find breast cancer in women at high Mirai risk
This will test whether adding a screening breast MRI finds more cancers in women whose mammograms are flagged as high risk by the Mirai AI model.
-
Community registry for cancer risk assessment and prevention
This study is collecting information from adults at higher risk for cancer to see how we can improve cancer screening and prevention in the community.
-
Collecting data to predict cancer risk in at-risk populations
This study is trying to collect samples and health information from people at higher risk of cancer to see if they can find signs that help predict cancer early on.
-
A program to collect cancer-related samples and data for better cancer care
This study is collecting blood, tissue, and other samples from people with cancer or at risk of it to help improve cancer care and treatment in the future.
-
Partnership with patients at risk of cancer
This study is collecting blood, tissue, and other samples from cancer patients and those at risk to see how it can help improve cancer care and support future research.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.